Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models.

Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models.

<h4>Background</h4>Although genotypic resistance testing (GRT) is recommended to guide combination antiretroviral therapy (cART), funding and/or facilities to perform GRT may not be available in low to middle income countries. Since treatment history (TH) impacts response to subsequent t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mattia C F Prosperi, Michal Rosen-Zvi, André Altmann, Maurizio Zazzi, Simona Di Giambenedetto, Rolf Kaiser, Eugen Schülter, Daniel Struck, Peter Sloot, David A van de Vijver, Anne-Mieke Vandamme, Anders Sönnerborg, EuResist study group, Virolab study group
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/133459cb09394a9d94e80aa53ce3dc4f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/133459cb09394a9d94e80aa53ce3dc4f

Ejemplares similares